add_action( 'wp_enqueue_scripts', 'iteck_child_theme_styles',3); function iteck_child_theme_styles() { wp_enqueue_style('iteck-parent-style', get_template_directory_uri(). '/style.css',array('bootstrap')); wp_enqueue_style('iteck-child-style', get_stylesheet_uri(), array( 'iteck-parent-style') ); } {"id":15661,"date":"2026-10-01T11:23:11","date_gmt":"2026-10-01T11:23:11","guid":{"rendered":"https:\/\/partnerlinkmz.com\/?p=15661"},"modified":"2026-10-01T11:23:11","modified_gmt":"2026-10-01T11:23:11","slug":"apremilast-a-cyklus-inzulinovych-pripravku","status":"publish","type":"post","link":"https:\/\/partnerlinkmz.com\/index.php\/2026\/10\/01\/apremilast-a-cyklus-inzulinovych-pripravku\/","title":{"rendered":"Apremilast a cyklus inzulinov\u00fdch p\u0159\u00edpravk\u016f"},"content":{"rendered":"

Apremilast je l\u00e9k, kter\u00fd se pou\u017e\u00edv\u00e1 p\u0159edev\u0161\u00edm k l\u00e9\u010db\u011b psori\u00e1zy a psoriatick\u00e9 artritidy. Je zn\u00e1m jako inhibitor fosfodiester\u00e1zy 4 (PDE4) a jeho \u00fa\u010dinky se projevuj\u00ed zejm\u00e9na v redukci z\u00e1n\u011btliv\u00fdch proces\u016f v t\u011ble. Posledn\u00ed v\u00fdzkumy nazna\u010duj\u00ed, \u017ee apremilast m\u016f\u017ee m\u00edt vliv i na metabolismus gluk\u00f3zy a inzulinovou citlivost, co\u017e vzbudilo z\u00e1jem o jeho spojen\u00ed s cyklem inzulinov\u00fdch p\u0159\u00edpravk\u016f.<\/p>\n

https:\/\/www.createinfo.ma\/2026\/09\/22\/apremilast-a-cyklus-inzulinovych-pripravku\/<\/a><\/p>\n

\u00da\u010dinky apremilastu na inzulinov\u00fd cyklus<\/h2>\n

Apremilast m\u016f\u017ee hr\u00e1t d\u016fle\u017eitou roli v regulaci inzulinov\u00e9ho cyklu d\u00edky n\u011bkolika mechanism\u016fm:<\/p>\n

    \n
  1. Redukce z\u00e1n\u011btu:<\/strong> Z\u00e1n\u011bt je kl\u00ed\u010dov\u00fdm faktorem, kter\u00fd ovliv\u0148uje inzulinovou rezistenci. Apremilast pom\u00e1h\u00e1 sni\u017eovat z\u00e1n\u011btliv\u00e9 marker\u016f v t\u011ble.<\/li>\n
  2. Zlep\u0161en\u00ed inzulinov\u00e9 citlivosti:<\/strong> N\u011bkter\u00e9 studie nazna\u010duj\u00ed, \u017ee apremilast m\u016f\u017ee zlep\u0161it citlivost tk\u00e1n\u00ed na inzulin, co\u017e je prosp\u011b\u0161n\u00e9 pro regulaci hladiny cukru v krvi.<\/li>\n
  3. Regulace metabolismu:<\/strong> Apremilast ovliv\u0148uje metabolick\u00e9 dr\u00e1hy, co\u017e m\u016f\u017ee p\u0159isp\u011bt k lep\u0161\u00edmu vyu\u017eit\u00ed gluk\u00f3zy v t\u011ble.<\/li>\n<\/ol>\n

    Praktick\u00e9 aplikace<\/h2>\n

    Vzhledem k pozitivn\u00edm vliv\u016fm apremilastu na inzulinov\u00fd cyklus by se jeho pou\u017eit\u00ed m\u011blo zva\u017eovat i u pacient\u016f trp\u00edc\u00edch metabolick\u00fdm syndromem nebo cukrovkou. Je d\u016fle\u017eit\u00e9, aby l\u00e9ka\u0159i sledovali \u00fa\u010dinky tohoto l\u00e9ku na metabolizmus pacient\u016f.<\/p>\n

    Z\u00e1v\u011br<\/h2>\n

    Apremilast m\u016f\u017ee m\u00edt v\u00fdznamn\u00fd vliv na cyklus inzulinov\u00fdch p\u0159\u00edpravk\u016f, a to zvl\u00e1\u0161t\u011b d\u00edky sv\u00e9mu protiz\u00e1n\u011btliv\u00e9mu \u00fa\u010dinku a schopnosti zlep\u0161ovat inzulinovou citlivost. Dal\u0161\u00ed v\u00fdzkum je v\u0161ak nezbytn\u00fd ke kompletn\u00edmu pochopen\u00ed v\u0161ech jeho potenci\u00e1ln\u00edch benefit\u016f v t\u00e9to oblasti.<\/p>\n","protected":false},"excerpt":{"rendered":"

    Apremilast je l\u00e9k, kter\u00fd se pou\u017e\u00edv\u00e1 p\u0159edev\u0161\u00edm k l\u00e9\u010db\u011b psori\u00e1zy a psoriatick\u00e9 artritidy. Je zn\u00e1m jako inhibitor fosfodiester\u00e1zy 4 (PDE4) a jeho \u00fa\u010dinky se projevuj\u00ed zejm\u00e9na v redukci z\u00e1n\u011btliv\u00fdch proces\u016f v t\u011ble. Posledn\u00ed v\u00fdzkumy nazna\u010duj\u00ed, \u017ee apremilast m\u016f\u017ee m\u00edt vliv i na metabolismus gluk\u00f3zy a inzulinovou citlivost, co\u017e vzbudilo z\u00e1jem o jeho spojen\u00ed s cyklem inzulinov\u00fdch p\u0159\u00edpravk\u016f. https:\/\/www.createinfo.ma\/2026\/09\/22\/apremilast-a-cyklus-inzulinovych-pripravku\/ \u00da\u010dinky apremilastu …<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-15661","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/partnerlinkmz.com\/index.php\/wp-json\/wp\/v2\/posts\/15661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/partnerlinkmz.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/partnerlinkmz.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/partnerlinkmz.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/partnerlinkmz.com\/index.php\/wp-json\/wp\/v2\/comments?post=15661"}],"version-history":[{"count":1,"href":"https:\/\/partnerlinkmz.com\/index.php\/wp-json\/wp\/v2\/posts\/15661\/revisions"}],"predecessor-version":[{"id":15662,"href":"https:\/\/partnerlinkmz.com\/index.php\/wp-json\/wp\/v2\/posts\/15661\/revisions\/15662"}],"wp:attachment":[{"href":"https:\/\/partnerlinkmz.com\/index.php\/wp-json\/wp\/v2\/media?parent=15661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/partnerlinkmz.com\/index.php\/wp-json\/wp\/v2\/categories?post=15661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/partnerlinkmz.com\/index.php\/wp-json\/wp\/v2\/tags?post=15661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}